Personnes se prêtant à la recherche : Questions médicales fréquentes
Nom anglais: Research Subjects
Descriptor UI:D035842
Tree Number:M01.774
Termes MeSH sélectionnés :
Methicillin-Resistant Staphylococcus aureus
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Personnes se prêtant à la recherche : Questions médicales les plus fréquentes",
"headline": "Personnes se prêtant à la recherche : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Personnes se prêtant à la recherche : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-25",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Personnes se prêtant à la recherche"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Personnes",
"url": "https://questionsmedicales.fr/mesh/D009272",
"about": {
"@type": "MedicalCondition",
"name": "Personnes",
"code": {
"@type": "MedicalCode",
"code": "D009272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "M01"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Personnes se prêtant à la recherche",
"alternateName": "Research Subjects",
"code": {
"@type": "MedicalCode",
"code": "D035842",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stephanie Morain",
"url": "https://questionsmedicales.fr/author/Stephanie%20Morain",
"affiliation": {
"@type": "Organization",
"name": "Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX."
}
},
{
"@type": "Person",
"name": "Kemal Hakan Gülkesen",
"url": "https://questionsmedicales.fr/author/Kemal%20Hakan%20G%C3%BClkesen",
"affiliation": {
"@type": "Organization",
"name": "Peter L. Reichertz Institute for Medical Informatics, TU Braunschweig and Hannover Medical School, Braunschweig, Germany."
}
},
{
"@type": "Person",
"name": "Reinhold Haux",
"url": "https://questionsmedicales.fr/author/Reinhold%20Haux",
"affiliation": {
"@type": "Organization",
"name": "Peter L. Reichertz Institute for Medical Informatics, TU Braunschweig and Hannover Medical School, Braunschweig, Germany."
}
},
{
"@type": "Person",
"name": "Sungwoo Um",
"url": "https://questionsmedicales.fr/author/Sungwoo%20Um",
"affiliation": {
"@type": "Organization",
"name": "Department of Ethics Education, Seoul National University, 1, Gwanak-Ro, 11-411, Gwanak-Gu, 08826, South Korea. sungwooum@snu.ac.kr."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Methicillin-resistant Staphylococcus aureus-associated orbital cellulitis: a case series.",
"datePublished": "2023-04-07",
"url": "https://questionsmedicales.fr/article/37029211",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-023-02698-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mptx2 defends against peritoneal infection by methicillin-resistant staphylococcus aureus.",
"datePublished": "2022-05-21",
"url": "https://questionsmedicales.fr/article/35609377",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2022.108856"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis.",
"datePublished": "2024-10-10",
"url": "https://questionsmedicales.fr/article/39390563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13052-024-01780-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children].",
"datePublished": "2024-01-22",
"url": "https://questionsmedicales.fr/article/38245868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.37201/req/113.2023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36371648",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/phar.2741"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Personnes",
"item": "https://questionsmedicales.fr/mesh/D009272"
},
{
"@type": "ListItem",
"position": 3,
"name": "Personnes se prêtant à la recherche",
"item": "https://questionsmedicales.fr/mesh/D035842"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Personnes se prêtant à la recherche - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Personnes se prêtant à la recherche",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Personnes se prêtant à la recherche",
"description": "Comment sont sélectionnés les sujets de recherche ?\nQuels tests sont effectués sur les sujets ?\nLes sujets sont-ils informés des risques ?\nComment évaluer la santé des sujets ?\nQuelles données sont collectées sur les sujets ?",
"url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Personnes se prêtant à la recherche",
"description": "Les sujets ressentent-ils des effets secondaires ?\nComment les symptômes sont-ils suivis ?\nLes symptômes varient-ils selon les traitements ?\nLes sujets peuvent-ils signaler des symptômes ?\nY a-t-il un suivi des symptômes après l'étude ?",
"url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Personnes se prêtant à la recherche",
"description": "Les sujets reçoivent-ils des conseils préventifs ?\nY a-t-il des vaccinations pour les sujets ?\nComment prévenir les effets indésirables ?\nLes sujets sont-ils formés à la prévention ?\nY a-t-il des recommandations diététiques ?",
"url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Personnes se prêtant à la recherche",
"description": "Quels types de traitements sont testés ?\nLes traitements sont-ils randomisés ?\nComment les traitements sont-ils administrés ?\nLes sujets reçoivent-ils un placebo ?\nComment évaluer l'efficacité des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Personnes se prêtant à la recherche",
"description": "Quelles complications peuvent survenir ?\nComment sont gérées les complications ?\nLes sujets sont-ils suivis après des complications ?\nLes complications sont-elles documentées ?\nY a-t-il des critères pour signaler des complications ?",
"url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Personnes se prêtant à la recherche",
"description": "Quels facteurs de risque sont évalués ?\nLes sujets sont-ils informés des facteurs de risque ?\nComment les facteurs de risque influencent-ils l'étude ?\nLes facteurs de risque sont-ils mesurés ?\nY a-t-il des interventions pour réduire les risques ?",
"url": "https://questionsmedicales.fr/mesh/D035842?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment sont sélectionnés les sujets de recherche ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les sujets sont choisis selon des critères spécifiques liés à l'étude."
}
},
{
"@type": "Question",
"name": "Quels tests sont effectués sur les sujets ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests cliniques, biologiques et d'imagerie peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Les sujets sont-ils informés des risques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'information sur les risques est essentielle avant le consentement."
}
},
{
"@type": "Question",
"name": "Comment évaluer la santé des sujets ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des évaluations médicales régulières sont effectuées tout au long de l'étude."
}
},
{
"@type": "Question",
"name": "Quelles données sont collectées sur les sujets ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des données démographiques, cliniques et de réponse au traitement sont collectées."
}
},
{
"@type": "Question",
"name": "Les sujets ressentent-ils des effets secondaires ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires peuvent survenir et doivent être signalés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils suivis ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont suivis par des questionnaires et des évaluations cliniques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les traitements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction du traitement administré."
}
},
{
"@type": "Question",
"name": "Les sujets peuvent-ils signaler des symptômes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les sujets sont encouragés à signaler tout symptôme nouveau ou aggravé."
}
},
{
"@type": "Question",
"name": "Y a-t-il un suivi des symptômes après l'étude ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi peut être proposé pour évaluer les effets à long terme."
}
},
{
"@type": "Question",
"name": "Les sujets reçoivent-ils des conseils préventifs ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conseils sur la santé et la prévention des maladies peuvent être fournis."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccinations pour les sujets ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccinations peuvent être administrées selon les protocoles de l'étude."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets indésirables ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures préventives et un suivi régulier aident à minimiser les effets indésirables."
}
},
{
"@type": "Question",
"name": "Les sujets sont-ils formés à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur la prévention des maladies peut être incluse dans l'étude."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations diététiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recommandations diététiques peuvent être fournies pour améliorer la santé des sujets."
}
},
{
"@type": "Question",
"name": "Quels types de traitements sont testés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments, des thérapies physiques et des interventions chirurgicales peuvent être testés."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils randomisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses études utilisent des méthodes randomisées pour réduire les biais."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils administrés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent être administrés par voie orale, intraveineuse ou topique."
}
},
{
"@type": "Question",
"name": "Les sujets reçoivent-ils un placebo ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certaines études, un groupe de sujets peut recevoir un placebo pour comparaison."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des mesures cliniques et des questionnaires standardisés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications liées aux traitements ou à la maladie peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment sont gérées les complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des interventions médicales appropriées."
}
},
{
"@type": "Question",
"name": "Les sujets sont-ils suivis après des complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi est souvent prévu pour évaluer la récupération des sujets."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles documentées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, toutes les complications doivent être soigneusement documentées dans l'étude."
}
},
{
"@type": "Question",
"name": "Y a-t-il des critères pour signaler des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des critères spécifiques sont établis pour le signalement des complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont évalués ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'âge, le sexe, et les antécédents médicaux sont évalués."
}
},
{
"@type": "Question",
"name": "Les sujets sont-ils informés des facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les sujets reçoivent des informations sur les facteurs de risque associés à l'étude."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque influencent-ils l'étude ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer les résultats et la généralisation des conclusions de l'étude."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque sont-ils mesurés ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des questionnaires et des évaluations médicales mesurent les facteurs de risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des interventions pour réduire les risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions peuvent être proposées pour réduire les facteurs de risque identifiés."
}
}
]
}
]
}
In recent years, methicillin-resistant Staphylococcus aureus (MRSA) orbital cellulitis (OC) has drawn increasing clinical and public health concern. We present a case series of MRSA OC encountered at ...
A multi-centre retrospective case series investigating MRSA OC in Australia from 2013 to 2022. Patients of all ages were included....
Nine cases of culture-positive non-multi-resistant MRSA (nmMRSA) OC were identified at four tertiary institutions across Australia (7 male, 2 female). Mean age was 17.1 ± 16.7 years (range 13-days to ...
NMMRSA OC can follow an aggressive clinical course causing severe orbital and intracranial complications across a wide demographic. However, early recognition, initiation of targeted antibiotics and s...
Methicillin-resistant Staphylococcus aureus (MRSA) has an increasing prevalence of multi-drug resistance. There is an urgent need for developing novel approaches to combat MRSA infection. Mucosal pent...
This study aims to identify risk factors associated with Methicillin-resistant Staphylococcus aureus (MRSA) infection in children diagnosed with acute osteomyelitis (AO) and to elucidate the laborator...
We conducted a retrospective analysis involving 123 children with acute osteomyelitis treated at our hospital. Upon admission, we measured white blood cell (WBC) counts, C-reactive protein (CRP) level...
The MRSA group had a significantly higher average age compared to the non-MRSA group (P < 0.05). Notably, the incidence of suppurative arthritis was significantly lower in the MRSA group (P < 0.05). A...
In children newly admitted with acute osteomyelitis, a CRP level exceeding 73.23 µg/mL may indicate a high likelihood of MRSA infection. For children with AO who have been hospitalized for three days ...
The objectives of this work were to know the prevalence of methicillin-resistant S. aureus (MRSA) infections in the paediatric population of our health department, to describe the risk factors for inf...
A retrospective, descriptive and analytical study of infections produced by MRSA versus those produced by MSSA was carried out during the years 2014 to 2018. Risk factors for MRSA infection were studi...
162 patients with S. aureus infections were identified. Of these, 25 (15.4%) were MRSA. The highest percentages of MRSA infection occurred among children who required hospital admission (23.4%). In th...
Our results suggest the need to review empirical local treatment regimen using drugs active against MRSA in infections of probable staphylococcal origin admitted to the hospital, especially if they ha...
The preferred antibiotic salvage regimen for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is unclear. We sought to evaluate the effectiveness and safety of vancomycin plus...
Single-center, retrospective cohort study between January 1, 2016, and December 31, 2021....
State University of New York Upstate University Hospital, a 748-bed tertiary care, academic medical center in Syracuse, NY....
Adult patients were included if they had blood cultures positive for MRSA ≥72 h, received vancomycin monotherapy initially, and received vancomycin plus ceftaroline for ≥24 h. Patients were excluded i...
Patients were medically complex with a median Pitt bacteremia score of 3, 63.3% (19/30) were admitted to the intensive care unit, and 66.7% (20/30) had infective endocarditis. Vancomycin-associated ac...
Vancomycin plus ceftaroline may represent an effective and well-tolerated salvage regimen option for persistent MRSAB....
Staphylococcus aureus is a common germ in bacterial infections in children. The rate of methicillin-resistant S. aureus (MRSA) is increasing lately....
The main aim is to know the rate of positive cultures to MRSA in Spanish pediatric emergency departments. The secondary aims are to analyse the risk factors for MRSA isolation (patient origin, history...
Retrospective multicenter study (07/01/2017-06/30/2018) with review of patient histories with isolation of S. aureus in samples of any origin obtained in 8 pediatric emergency departments of the Infec...
During this period, S. aureus was detected in 403 patients (average age 75.8 ± 59.2 months; 54.8% male): 28.8% hospital-related infections (HRI) and 71.2% community-related infections (CRI). Overall, ...
The overall MRSA rate was one in 6 staphylococcal infections. Higher MRSA rates were detected in samples of suppurating skin injuries and in foreign children or in children with a history of previous ...
We aimed to determine the synergistic effects of ceftaroline (CPT) in combination with daptomycin (DAP), vancomycin (VAN), or linezolid (LNZ) against various methicillin-resistant Staphylococcus aureu...
MRSA strains randomly selected from 2014 to 2018 were studied. Checkerboard titration and in vitro time-kill analyses were used to determine the synergistic activities of the antibiotic combinations....
A total of 10 genetically distinct MRSA strains were included in this study. The checkerboard titration analysis revealed that the CPT-DAP, CPT-VAN, and CPT-LNZ combinations had a synergistic effect a...
The CPT-DAP combination showed better synergistic activity than the CPT-VAN and CPT-LNZ combinations against the enrolled MRSA strains. DAP, rather than VAN or LNZ, might be a better choice for CPT co...
The methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) has a high negative predictive value (NPV). We aimed to understand if there was a difference in the NPV of the MR...
We performed a single-center, retrospective cohort study of adults with a positive respiratory culture and MRSA nasal PCR admitted to a surgical ICU from 2016 to 2019. Patients were stratified by surg...
We analyzed 61 patients: 42.6% (n = 26) ACS-ICU and 57.4% (n = 35) CVICU. There were no differences in age, comorbidities, prior MRSA infection, recent antibiotic use, immunocompromised status, or ren...
The MRSA nasal PCR screen has a high NPV for ruling out MRSA pneumonia in critically ill surgical patients. However, patients in the CVICU and patients hospitalized ≥5 d had a longer time to de-escala...
Severe infections of virulent methicillin-resistant Staphylococcus aureus (MRSA) are a serious health problem. The present study aimed to investigate clonal spread, virulence and antimicrobial resista...
Molecular identification and mecA gene detection were performed with PCR. Clonal relatedness was evaluated by RAPD PCR and MLST. MRSA epidemiology, virulence and resistance patterns were investigated ...
All 27 isolates were identified as S. aureus and were mecA positive, and all were susceptible to linezolid, tigecycline and vancomycin. The toxin genes hlg (in 92.6% of isolates), seb (77.8%), sei (77...
To the best of our knowledge, this study is the first describing the clonal spreading of Bulgarian MRSA and the association with their virulence and resistance determinants. Monitoring of MRSA epidemi...
Endoscopic endonasal approach (EEA) procedures are inherently contaminated due to direct access through the nasopharyngeal mucosa. The reported rate of postoperative meningitis in EEA procedures is 0....
All adult patients who underwent EEA resection at our institution from 2013 to 2021 were retrospectively reviewed. Patients with preoperative cerebrospinal fluid infections were excluded. Data includi...
Of 483 patients identified (mean age, 51 years; range, 18-90 years; 274 [56.7%] female), 80 (16.6%) had a positive preoperative methicillin-resistant Staphylococcus aureus (MRSA)/methicillin-sensitive...
Postoperative rates of meningitis after EEA surgery were not significantly changed based on MRSA/MSSA colonization status of the patient or preoperative decolonization. The utility of preoperative tes...